326 related articles for article (PubMed ID: 7805626)
1. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
[TBL] [Abstract][Full Text] [Related]
2. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
Suenson E; Bjerrum P; Holm A; Lind B; Meldal M; Selmer J; Petersen LC
J Biol Chem; 1990 Dec; 265(36):22228-37. PubMed ID: 2148318
[TBL] [Abstract][Full Text] [Related]
3. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
Suenson E; Thorsen S
Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
[TBL] [Abstract][Full Text] [Related]
4. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.
Suenson E; Petersen LC
Biochim Biophys Acta; 1986 Apr; 870(3):510-9. PubMed ID: 2938632
[TBL] [Abstract][Full Text] [Related]
5. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
Fischer BE; Will H
Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
[TBL] [Abstract][Full Text] [Related]
7. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.
Higgins DL; Vehar GA
Biochemistry; 1987 Dec; 26(24):7786-91. PubMed ID: 2962641
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation.
Beckmann R; Geiger M; Binder BR
J Biol Chem; 1988 May; 263(15):7176-80. PubMed ID: 2966802
[TBL] [Abstract][Full Text] [Related]
9. Structural studies of fibrinolysis by electron microscopy.
Veklich Y; Francis CW; White J; Weisel JW
Blood; 1998 Dec; 92(12):4721-9. PubMed ID: 9845538
[TBL] [Abstract][Full Text] [Related]
10. Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.
Fredenburgh JC; Nesheim ME
J Biol Chem; 1992 Dec; 267(36):26150-6. PubMed ID: 1464625
[TBL] [Abstract][Full Text] [Related]
11. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
Carr ME; Alving BM
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
[TBL] [Abstract][Full Text] [Related]
13. The effect of fibrin structure on fibrinolysis.
Gabriel DA; Muga K; Boothroyd EM
J Biol Chem; 1992 Dec; 267(34):24259-63. PubMed ID: 1447176
[TBL] [Abstract][Full Text] [Related]
14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
16. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
Petersen LC; Suenson E
Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
[TBL] [Abstract][Full Text] [Related]
17. Fibrin-mediated plasminogen activation.
Nieuwenhuizen W
Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
[TBL] [Abstract][Full Text] [Related]
18. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy.
Weisel JW; Nagaswami C; Korsholm B; Petersen LC; Suenson E
J Mol Biol; 1994 Jan; 235(3):1117-35. PubMed ID: 8289311
[TBL] [Abstract][Full Text] [Related]
19. Influence of homocysteine on fibrin network lysis.
Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
